Genotyping and Molecular Characterization of Hepatitis B Virus from Human Immunodeficiency Virus-Infected Individuals in Southern Africa

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Makondo, Euphodia ^a   Bell, Trevor G ^a   Kramvis, Anna ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALANINE; ANTIRETROVIRUS AGENT; ARGININE; ASPARAGINE; ASPARTIC ACID; CYTOSINE; GLUTAMINE; GLYCINE; GUANINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HISTIDINE; LEUCINE; LYSINE; METHIONINE; SERINE; THREONINE; THYMINE; VALINE; VIRUS DNA;

ADULT; ANTIGEN EXPRESSION; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROMOTER REGION; SEX DIFFERENCE; SOUTH AFRICA; TRANSLATION INITIATION; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS MUTATION; VIRUS STRAIN;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; COINFECTION; FEMALE; GENE EXPRESSION; GENOTYPING TECHNIQUES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEX FACTORS; SOUTH AFRICA; TIME FACTORS; VIRAL LOAD;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84867010760     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046345     Document Type: Article

References (91)

1. Kramvis A, Kew MC, (2007) Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res 37: S9-S19.
2. UNAIDS (2010) UNAIDS report on the global AIDS epidemic 2010. Available: http://www.unaids.org/en/dataanalysis/. Accessed 2011 November 16.
3. Acar A, Kemahli S, Altunay H, Kosan E, Oncul O, et al. (2010) HBV, HCV and HIV seroprevalence among blood donors in Istanbul, Turkey: how effective are the changes in the national blood transfusion policies? Braz J Infect Dis 14: 41-46.
4. Kottilil S, Jackson JO, Polis MA, (2005) Hepatitis B & hepatitis C in HIV-infection. Indian J Med Res 121: 424-450.
5. Burnett RJ, Francois G, Kew MC, Leroux-Roels G, Meheus A, et al. (2005) Hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int 25: 201-213.
6. Botha JF, Ritchie MJ, Dusheiko GM, Mouton HW, Kew MC, (1984) Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet 1: 1210-1212.
7. Di Bisceglie AM, Dusheiko GM, Kew MC, (1985) Detection of markers of hepatitis B virus infection in urine of chronic carriers. J Med Virol 16: 337-341.
8. Kew MC, (1996) Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 38 Suppl 2: S31-36.
9. Vardas E, Mathai M, Blaauw D, McAnerney J, Coppin A, et al. (1999) Preimmunization epidemiology of hepatitis B virus infection in South African children. J Med Virol 58: 111-115.
10. Hoffmann CJ, Charalambous S, Martin DJ, Innes C, Churchyard GJ, et al. (2008) Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis 47: 1479-1485.
11. Barth RE, Huijgen Q, Tempelman HA, Mudrikova T, Wensing AM, et al. (2011) Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa. J Med Virol 83: 929-934.
12. Burnett RJ, Ngobeni JM, Francois G, Hoosen AA, Leroux-Roels G, et al. (2007) Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women. Int J STD AIDS 18: 152-156.
13. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ, (2009) Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. J Med Virol 81: 406-412.
14. Mphahlele MJ, Lukhwareni A, Burnett RJ, Moropeng LM, Ngobeni JM, (2006) High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. J Clin Virol 35: 14-20.
15. Firnhaber C, Reyneke A, Schulze D, Malope B, Maskew M, et al. (2008) The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J 98: 541-544.
16. Firnhaber C, Viana R, Reyneke A, Schultze D, Malope B, et al. (2009) Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa. Int J Infect Dis 13: 488-492.
17. Firnhaber C, Chen CY, Evans D, Maskew M, Schulz D, et al. (2012) Prevalence of hepatitis B virus (HBV) co-infection in HBV serologically-negative South African HIV patients and retrospective evaluation of the clinical course of mono- and co-infection. Int J Infect Dis 16: e268-272.
18. Boyles TH, Cohen K, (2011) The prevalence of hepatitis B infection in a rural South African HIV clinic. S Afr Med J 101: 470-471.
19. Matthews GV, Manzini P, Hu Z, Khabo P, Maja P, et al. (2011) Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa. AIDS 25: 1727-1735.
20. Bell TG, Makondo E, Martinson MA, Kramvis A, (2012) Hepatitis B Virus Infection in Human Immunodeficiency Virus Infected Southern African Adults: Occult or Overt- That is the Question. PlosOne (in press) pp. e45750 doi:10.1371/journal.pone.0045750.
21. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, et al. (2008) Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49: 652-657.
22. Fares MA, Holmes EC, (2002) A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54: 807-814.
23. Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, et al. (1989) Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci U S A 86: 7059-7062.
24. Gunther S, Sommer G, Von Breunig F, Iwanska A, Kalinina T, et al. (1998) Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol 36: 531-538.
25. Norder H, Courouce AM, Magnius LO, (1992) Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 73 (Pt 12) (): 3141-3145.
26. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, et al. (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69 (Pt 10) (): 2575-2583.
27. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO, et al. (2008) Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 80: 27-46.
28. Norder H, Courouce AM, Magnius LO, (1994) Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198: 489-503.
29. Naumann H, Schaefer S, Yoshida CF, Gaspar AM, Repp R, et al. (1993) Identification of a new hepatitis B virus (HBV) genotype from Brazil that expresses HBV surface antigen subtype adw4. J Gen Virol 74 (Pt 8) (): 1627-1632.
30. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, et al. (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81: 67-74.
31. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO, (2002) Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83: 2059-2073.
32. Yu H, Yuan Q, Ge SX, Wang HY, Zhang YL, et al. (2010) Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I". PLoS One 5: e9297.
33. Arankalle VA, Gandhe SS, Borkakoty BJ, Walimbe AM, Biswas D, et al. (2010) A novel HBV recombinant (genotype I) similar to Vietnam/Laos in a primitive tribe in eastern India. J Viral Hepat pp. 501-510.
34. Tran TT, Trinh TN, Abe K, (2008) New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 82: 5657-5663.
35. Olinger CM, Jutavijittum P, Hubschen JM, Yousukh A, Samountry B, et al. (2008) Possible new hepatitis B virus genotype, southeast Asia. Emerg Infect Dis 14: 1777-1780.
36. Osiowy C, Kaita K, Solar K, Mendoza K, (2010) Molecular characterization of hepatitis B virus and a 9-year clinical profile in a patient infected with genotype I. J Med Virol 82: 942-948.
37. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, et al. (2009) A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 83: 10538-10547.
38. Kramvis A, Kew M, Francois G, (2005) Hepatitis B virus genotypes. Vaccine 23: 2409-2423.
39. Kimbi GC, Kramvis A, Kew MC, (2004) Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa. J Gen Virol 85: 1211-1220.
40. Kramvis A, Kew MC, (2005) Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat 12: 456-464.
41. Takahashi K, Aoyama K, Ohno N, Iwata K, Akahane Y, et al. (1995) The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. J Gen Virol 76 (Pt 12) (): 3159-3164.
42. Vermeulen M, Dickens C, Lelie N, Walker E, Coleman C, et al. (2012) Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk. Transfusion 52: 880-892.
43. Nicholas K, Nicholas HBJ (1997) GeneDoc: Analysis and Visualization of Genetic Variation. Available: http://www.psc.edu/biomed/genedoc. Accessed 2010 November.
44. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
45. Xia X (2000) Data analysis in molecular biology and evolution Boston, Dordrecht, London: Kluwer Academic Publishers.
46. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
47. Kimura M, (1980) A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16: 111-120.
48. Kramvis A, Kew MC, (2007) Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus. Hepatol Res 37: S27-32.
49. Chen CY, Crowther C, Kew MC, Kramvis A, (2008) A valine to phenylalanine mutation in the precore region of hepatitis B virus causes intracellular retention and impaired secretion of HBe-antigen. Hepatol Res 38: 580-592.
50. Bowyer SM, van Staden L, Kew MC, Sim JG, (1997) A unique segment of the hepatitis B virus group A genotype identified in isolates from South Africa. J Gen Virol 78 (Pt 7) (): 1719-1729.
51. Pastore G, Santantonio T, Monno L, Milella M, Luchena N, et al. (1988) Effects of HIV superinfection on HBV replication in a chronic HBsAg carrier with liver disease. J Hepatol 7: 164-168.
52. Thio CL, (2009) Hepatitis B and human immunodeficiency virus coinfection. Hepatology 49: S138-145.
53. Vento S, Di Perri G, Garofano T, Concia E, Bassetti D, (1989) Reactivation of hepatitis B in AIDS. Lancet 2: 108-109.
54. Audsley J, Arrifin N, Yuen LK, Ayres A, Crowe SM, et al. (2009) Prolonged use of tenofovir in HIV/hepatitis B virus (HBV)-coinfected individuals does not lead to HBV polymerase mutations and is associated with persistence of lamivudine HBV polymerase mutations. HIV Med 10: 229-235.
55. Quarleri J, Moretti F, Bouzas MB, Laufer N, Carrillo MG, et al. (2007) Hepatitis B virus genotype distribution and its lamivudine-resistant mutants in HIV-coinfected patients with chronic and occult hepatitis B. AIDS Res Hum Retroviruses 23: 525-531.
56. Allain JP, Belkhiri D, Vermeulen M, Crookes R, Cable R, et al. (2009) Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 49: 1868-1876.
57. Collinson MA, Tollman SM, Kahn K, (2007) Migration, settlement change and health in post-apartheid South Africa: triangulating health and demographic surveillance with national census data. Scand J Public Health Suppl 69: 77-84.
58. Zhou Y, Holmes EC, (2007) Bayesian estimates of the evolutionary rate and age of hepatitis B virus. J Mol Evol 65: 197-205.
59. Buckwold VE, Xu Z, Yen TS, Ou JH, (1997) Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol 78 (Pt 8) (): 2055-2065.
60. Ahn SH, Kramvis A, Kawai S, Spangenberg HC, Li J, et al. (2003) Sequence variation upstream of precore translation initiation codon reduces hepatitis B virus e antigen production. Gastroenterology 125: 1370-1378.
61. Laras A, Koskinas J, Avgidis K, Hadziyannis SJ, (1998) Incidence and clinical significance of hepatitis B virus precore gene translation initiation mutations in e antigen-negative patients. J Viral Hepat 5: 241-248.
62. Hou J, Lin Y, Waters J, Wang Z, Min J, et al. (2002) Detection and significance of a G1862T variant of hepatitis B virus in Chinese patients with fulminant hepatitis. J Gen Virol 83: 2291-2298.
63. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, et al. (1989) Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2: 588-591.
64. Baptista M, Kramvis A, Kew MC, (1999) High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29: 946-953.
65. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, et al. (2001) A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Japan HBV Genotype Research Group. Hepatology 33: 218-223.
66. Yeh CT, So M, Ng J, Yang HW, Chang ML, et al. (2010) Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology 52: 1922-1933.
67. Chen WN, Oon CJ, (2000) Mutations and deletions in core promoter and precore stop codon in relation to viral replication and liver damage in Singaporean hepatitis B virus carriers. Eur J Clin Invest 30: 787-792.
68. Zhang D, Ma S, Zhang X, Zhao H, Ding H, et al. (2012) Prevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression. BMC Infect Dis 10: 271.
69. Audsley J, Littlejohn M, Yuen L, Sasadeusz J, Ayres A, et al. (2010) HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing. Virology 405: 539-547.
70. Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J, (2005) Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol 75: 513-521.
71. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, et al. (2004) Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25: 2023-2032.
72. Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, et al. (2006) High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology 130: 1153-1168.
73. Hildt E, Saher G, Bruss V, Hofschneider PH, (1996) The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology 225: 235-239.
74. Yeung P, Wong DK, Lai CL, Fung J, Seto WK, et al. (2011) Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J Infect Dis 203: 646-654.
75. Lin CM, Wang GM, Jow GM, Chen BF, (2012) Functional analysis of hepatitis B virus pre-s deletion variants associated with hepatocellular carcinoma. J Biomed Sci 19: 17.
76. Kim HS, Ryu CJ, Hong HJ, (1997) Hepatitis B virus preS1 functions as a transcriptional activation domain. J Gen Virol 78 (Pt 5) (): 1083-1086.
77. Paulij WP, de Wit PL, Sunnen CM, van Roosmalen MH, Petersen-van Ettekoven A, et al. (1999) Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen. J Gen Virol 80 (Pt 8) (): 2121-2126.
78. Gutierrez C, Devesa M, Loureiro CL, Leon G, Liprandi F, et al. (2004) Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. J Med Virol 73: 200-207.
79. Bock CT, Tillmann HL, Torresi J, Klempnauer J, Locarnini S, et al. (2002) Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 122: 264-273.
80. Torresi J, Earnest-Silveira L, Civitico G, Walters TE, Lewin SR, et al. (2002) Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 299: 88-99.
81. Salisse J, Sureau C, (2009) A function essential to viral entry underlies the hepatitis B virus "a" determinant. J Virol 83: 9321-9328.
82. Torresi J, (2002) The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 25: 97-106.
83. Torresi J, Earnest-Silveira L, Deliyannis G, Edgtton K, Zhuang H, et al. (2002) Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293: 305-313.
84. Henke-Gendo C, Amini-Bavil-Olyaee S, Challapalli D, Trautwein C, Deppe H, et al. (2008) Symptomatic hepatitis B virus (HBV) reactivation despite reduced viral fitness is associated with HBV test and immune escape mutations in an HIV-coinfected patient. J Infect Dis 198: 1620-1624.
85. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, et al. (1998) Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27: 1670-1677.
86. Delaney WEt, Yang H, Westland CE, Das K, Arnold E, et al. (2003) The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol 77: 11833-11841.
87. Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, et al. (2007) Mutations associated with lamivudine-resistance in therapy-naive hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. J Med Virol 79: 1650-1654.
88. Selabe SG, Song E, Burnett RJ, Mphahlele MJ, (2009) Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes. J Med Virol 81: 996-1001.
89. Thio CL, Seaberg EC, Skolasky R, Phair J, Visscher B, et al. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360: 1921-1926.
90. Iacomi F, Vincenti D, Vairo F, Solmone M, Mariano A, et al. (2009) Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B. J Med Virol 81: 1151-1156.
91. Gous N, Bhimma R, Kew M, Kramvis A, (2010) Retrospective characterization of the S open reading frame of HBV isolated from children with membranous nephropathy treated with interferon-alpha2b. Antivir Ther 15: 61-69.